Oncternal Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Oncternal Therapeutics, Inc. Website Screenshot

http://www.oncternal.com

Oncternal Therapeutics, Inc. Company Intro

Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. We’re committed to translate pioneering areas of cancer research into approved therapies that can be used to treat multiple cancer types.

Industry

Healthcare

Oncternal Therapeutics, Inc. Headquaters

12230 El Camino Real
San Diego,92130
United States


Oncternal Therapeutics, Inc. Share price

14 Dec 2021 18:04 GMT

$2.5400

-0.02 (-0.78 %)


Oncternal Therapeutics, Inc. Market cap

$126.877 M


WMC RANKING

2022

Oncternal Therapeutics, Inc. # 239

Biotechnology

Latest Oncternal Therapeutics, Inc. News

News 06 Jan 2022

23 Stocks Moving in Thursday's Pre-Market Session - Benzinga

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday.

News 06 Jan 2022

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) Receives Consensus Rating of "Buy" from Brokerages

Oncternal Therapeutics, Inc. (NASDAQ:ONCT) has been given a consensus recommendation of "Buy" by the six brokerages that are covering the company,...

News 06 Jan 2022

EDELWEISS 3 Trial Positive Topline Results: ObsEva S.A. (OBSV) stock Hikes Premarket

ObsEva S.A. (OBSV) stock became bullish premarket on the news of its positive topline data from its Phase 3 trial of Linzagolix.


WMC Market Score


WMC Market to Revenue Score


Oncternal Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Currency Revenue Expense Profit Market Cap WMC Sector Score
Oncternal Therapeutics, Inc. USD $3,545 $22,295 $-18,435 $1,269M 239
Regeneron Pharmaceuticals, Inc. USD $9,197,600 $3,997,800 $4,003,800 $713,370B 1
Vertex Pharmaceuticals Incorporated USD $6,414,881 $2,617,257 $2,762,032 $539,620B 2
Alexion Pharmaceuticals, Inc. USD $6,261,601 $2,747,200 $681,800 $ 3
Incyte Corporation USD $2,702,913 $2,048,306 $478,480 $150,540B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Oncternal Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Oncternal Therapeutics, Inc. Post vs Top 4 Industry Competitors




Oncternal Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors



Oncternal Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors



Oncternal Therapeutics, Inc. WMC Market Score Calculations


Details Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Oncternal Therapeutics, Inc. 0.04 0 0 0 0 0 0
Regeneron Pharmaceuticals, Inc. 100 25.50 16.15 22 0 0 28.52
Vertex Pharmaceuticals Incorporated 69.75 35.68 8.95 33 0 0 34.78
Alexion Pharmaceuticals, Inc. 68.08 100 100 22 0 0 100
Incyte Corporation 29.39 5.03 0.04 100 0 0 47.37

Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields


You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries